Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh
· Delayed Price · Currency is BDT 13.10
-0.10 (-0.76%)
At close: Aug 13, 2025
DSE:IBP Revenue
Indo-Bangla Pharmaceuticals had revenue of 21.89M BDT in the quarter ending March 31, 2025, with 14.55% growth. This brings the company's revenue in the last twelve months to 91.10M, down -56.95% year-over-year. In the fiscal year ending June 30, 2024, Indo-Bangla Pharmaceuticals had annual revenue of 176.64M, down -52.83%.
Revenue (ttm)
91.10M
Revenue Growth
-56.95%
P/S Ratio
16.58
Revenue / Employee
599.33K
Employees
152
Market Cap
1.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 176.64M | -197.84M | -52.83% |
| Jun 30, 2023 | 374.48M | -110.20M | -22.74% |
| Jul 1, 2022 | 484.68M | -297.56M | -38.04% |
| Jul 1, 2021 | 782.24M | -83.86M | -9.68% |
| Jun 30, 2020 | 866.10M | 125.38M | 16.93% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jul 1, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grameenphone | 156.27B |
| Square Pharmaceuticals PLC. | 75.86B |
| British American Tobacco Bangladesh Company | 91.37B |
| Robi Axiata PLC. | 97.26B |
| BRAC Bank PLC. | 68.39B |
| Walton Hi-Tech Industries | 78.24B |
| Bangladesh Export Import Company | 17.72B |
| Marico Bangladesh | 17.06B |